Pri-Med Baton Rouge

Baton Rouge, LA | December 11-12, 2018

Renaissance Baton Rouge

Putting the Patient First: Best Practices in Managing Cardiovascular Risk and Other Modifiable Risk Factors


Cardiovascular disease, obesity, and diabetes are closely linked, physiologically and epidemiologically. This session reviews the latest evidence on the management of hypertension, dyslipidemia, and cardiovascular risk in the patient with diabetes. Learn to assess cardiovascular risk, interpret guidelines, and optimize therapy for your complex cardiometabolic patients. Lastly, understand the role that newer diabetes therapies can play in reducing cardiovascular risk in patients with diabetes.

Learning Objectives

Apply current evidence and proven clinical strategies to reduce comorbid cardiovascular risk and complications of diabetes, including heart failure, hypertension, dyslipidemia, coronary artery disease, and stroke

Describe the pathophysiologic links between diabetes and cardiovascular disease

Evaluate potential cardiovascular impact when selecting antihyperglycemic agents


Download a PDF of the presented slides.



Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASH

Keith C Ferdinand, MD, is Professor of Clinical Medicine at the Tulane University School of Medicine and the Tulane Heart and Vascular Institute in New Orleans, Louisiana. He was previously Professor of Clinical Pharmacology at Xavier University, New...

View Full Bio

Educational Partners

Commercial Supporters

Lilly. For further information concerning Lilly grant funding visit, Merck & Co., Inc., Novo Nordisk Inc., Sanofi US